6 Health Care Stocks – RMD, RHC, SHL, CSL, BIT And RHT

If an investor is looking for the safest sectors in Australia, health care will be among the top few sectors even during uncertain times. As the aging population in developed countries continue to grow the need for health care will always be there for people. For the last three years, the S&P/ASX 200 health care (AUD) currently at 1,680.66, has been on an upward trend, except in the last three months owing to the market volatility. Here are six stocks under healthcare which are worth a watch.

RESMED INC (ASX: RMD) – Resmed is a world-leading connected health company which reported a revenue increase of 12% to $588.3 million which is up 13% on a constant currency basis. The company’s net income increased by 23% with diluted earnings per share of $0.73. The cash from operations of the company for the quarter was $48.1 million as compared to net income in the current quarter of $105.7 million. However, the stock price went down today by -0.502% to $15.860 which is trading at a 52-week high as on December 14, 2018. The market capitalization at current price is at $15.860 as of today December 14, 2018.

RAMSAY HEALTH CARE LIMITED (ASX: RHC) – The company earnings before interest & tax is up 6.8% on previous year $1.008 billion, helped with the revenue of $9.2 billion which is up by 5.4%. The company saw an increase in net profit after tax of $579.3 million which is up 6.8% on previous year. The core earnings per share are up by 7.0% on the previous year, and the company has a history of earnings growth. Australian hospitals are performing well despite industry headwinds, demonstrating strength and diversity of portfolio. However, the stock price went up by 0.074% to $54.430. The market capitalization at current price is at $54.430 as of today December 14, 2018.

SONIC HEALTHCARE LIMITED (ASX: SHL) – The company has completed the bookbuild for its A$600 million institutional placement. At an issue price of A$19.50 per new share, the placement will result in the issue of 30,769,231 new ordinary shares in the company and the proceeds from the Placement were used to fund Sonic’s acquisition of Aurora Diagnostics, LLC partially. The company has a decent P/E of 19.390, and the EPS is 1.126 AUD when compared to the peer basket. However, the stock price went up by 2.519% to $22.380. In the past 12 months the stock faced a decline of -4.84% in the performance as at December 14, 2018.

CSL LIMITED (ASX: CSL) – CSL’s continuing priority is to ensure the ongoing safety and quality of their medicines. The company also reported a return on invested capital of 25.9 percent. The basic earnings per share of the FY are $3.822. The company’s P/E is on a higher side at 35.130 and EPS is of an attractive 5.171 AUD which reflects the profitability of the company. However, the stock price went down by 0.826% to $180.150. The company is continuing to innovate in areas of business strength, developing new opportunities in areas of unmet need. The market capitalization at the current market price is of $82.28 billion.

BIOTRON LIMITED (ASX: BIT) – The company ends 2018 in a robust position with strong financials resulting from the funds and the positive data from the Phase 2 HIV?1 clinical trial in hand. As reported in early December the company has raised a total of $4.7 million to bring the current cash balance to $7.1 million. The company had received $1.07 million R&D tax refund in Oct ’18 and underwriting agreement for 30 Nov 2018, and $0.06 options in Oct ’18 will bring in $4.7 million. However, the stock price went down by 4.348% to $0.110. The market capitalization of the stock at current price is $62.83 million.

RESONANCE HEALTH LIMITED (ASX: RHT) – The total receipts from customers for the year were $2.65m, up by 16% from the previous year’s result. The company forecasted revenue of approx. The available cash was $2.03 million with no debt. RHT has a high P/E ratio of 126.670x and the EPS of 0.001 AUD which signifies the higher growth in the future. The company’s net profit after tax was of $224,619 for FY 2017/18 including employee share-based payments. However, the stock price went down by 6.579% to $ 0.071. The market capitalization of the stock at current market price is $30.59 million as at December 14, 2018.


Disclaimer

This website is a service of Kalkine Media Pty. Ltd. A.C.N. 629 651 672. The website has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Kalkine Media does not in any way endorse or recommend individuals, products or services that may be discussed on this site. Our publications are NOT a solicitation or recommendation to buy, sell or hold. We are neither licensed nor qualified to provide investment advice.

Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.


6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report